<?xml version="1.0"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "JATS-journalpublishing1.dtd"[]>
<article xml:lang="en" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" dtd-version="1.2" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">IJPDS</journal-id>
<journal-title-group>
<journal-title>International Journal of Population Data Science</journal-title>
<abbrev-journal-title>IJPDS</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2399-4908</issn>
<publisher>
<publisher-name>Swansea University</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.23889/ijpds.v11i5.3511</article-id>
<article-id pub-id-type="publisher-id">11:5:3511</article-id>
<article-id pub-id-type="pii">S2399490821035114</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Population Data Science</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>COVID-19 Public Health and Social Measures (PHSM) and early childhood developmental concerns in Scotland: an interrupted time series analysis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Hardie</surname><given-names initials="I">Iain</given-names></name><xref ref-type="aff" rid="affil-1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author"><name><surname>Marryat</surname><given-names initials="L">Louise</given-names></name><xref ref-type="aff" rid="affil-2"><sup>2</sup></xref></contrib>
<contrib contrib-type="author"><name><surname>Murray</surname><given-names initials="A">Aja</given-names></name><xref ref-type="aff" rid="affil-1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author"><name><surname>King</surname><given-names initials="J">Josiah</given-names></name><xref ref-type="aff" rid="affil-1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author"><name><surname>Okelo</surname><given-names initials="K">Kenneth</given-names></name><xref ref-type="aff" rid="affil-1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author"><name><surname>Fenton</surname><given-names initials="L">Lynda</given-names></name><xref ref-type="aff" rid="affil-3"><sup>3</sup></xref></contrib>
<contrib contrib-type="author"><name><surname>Stevely</surname><given-names initials="A">Abigail</given-names></name><xref ref-type="aff" rid="affil-4"><sup>4</sup></xref></contrib>
<contrib contrib-type="author"><name><surname>Boardman</surname><given-names initials="J">James</given-names></name><xref ref-type="aff" rid="affil-5"><sup>5</sup></xref></contrib>
<contrib contrib-type="author"><name><surname>Lombardo</surname><given-names initials="M">Michael</given-names></name><xref ref-type="aff" rid="affil-6"><sup>6</sup></xref></contrib>
<contrib contrib-type="author"><name><surname>Stock</surname><given-names initials="S">Sarah</given-names></name><xref ref-type="aff" rid="affil-7"><sup>7</sup></xref></contrib>
<aff id="affil-1"><label>1</label><institution>Department of Psychology, School of Philosophy, Psychology and Language Sciences, University of Edinburgh, Edinburgh, United Kingdom</institution></aff>
<aff id="affil-2"><label>2</label><institution>School of Health Sciences, University of Dundee, Dundee, United Kingdom</institution></aff>
<aff id="affil-3"><label>3</label><institution>Public Health Scotland, Edinburgh and Glasgow, United Kingdom</institution></aff>
<aff id="affil-4"><label>4</label><institution>Sheffield Addictions Research Group, School of Medicine and Population Health, University of Sheffield, Sheffield, United Kingdom</institution></aff>
<aff id="affil-5"><label>5</label><institution>Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom; Institute for Regeneration and Repair, Edinburgh, United Kingdom</institution></aff>
<aff id="affil-6"><label>6</label><institution>Laboratory for Autism and Neurodevelopmental Disorders, Center for Neuroscience and Cognitive Systems, Istituto Italiano di Tecnologia, Rovereto, Italy</institution></aff>
<aff id="affil-7"><label>7</label><institution>Usher Institute, University of Edinburgh, Edinburgh, United Kingdom</institution></aff>
</contrib-group>
<pub-date date-type="pub" publication-format="electronic"><day></day><month></month><year></year></pub-date>
<pub-date date-type="collection" publication-format="electronic"><year></year></pub-date>
<volume>11</volume>
<issue>5</issue>
<elocation-id>3511</elocation-id>
<permissions>
<license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
<license-p>This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.</license-p>
</license>
</permissions>
<self-uri xlink:href="https://ijpds.org/article/view/3511">This article is available from the IJPDS website at: https://ijpds.org/article/view/3511</self-uri>
<abstract>
<sec>
<title>Background</title>
<p>COVID-19 public health and social measures (PHSM) may have affected children’s development, for example by reducing their interaction with others. We examined associations between PHSM and developmental concerns among young children in Scotland.</p>
</sec>
<sec>
<title>Methods</title>
<p>We utilised data from routine 13–15 month and 27–30 month child health reviews, covering 257,532 children in Scotland who took part in reviews between January 2019 and August 2023. Interrupted time-series analysis assessed slope changes in the weekly proportion of children with health visitor-identified developmental concerns following the March 2020 introduction of, and August 2021 removal of, PHSM. Outcomes were any 13–15 month and 27–30 month developmental concerns, and domain-specific concerns regarding speech-language-communication, problem-solving, gross-motor, personal-social, emotional-behavioural and fine-motor development.</p>
</sec>
<sec>
<title>Findings</title>
<p>The March 2020 PHSM introduction was associated with a slope change increase in the proportion of children with any developmental concerns (+0.091 percentage points per week [95% CI: 0.065, 0.116] at 13–15 months and +0.076 percentage points per week [95% CI: 0.048, 0.104] at 27–30 months. The August 2021 PHSM removal was associated with a slope change decrease in the proportion of children with any developmental concerns at 27–30 months (-0.067 percentage points per week [95% CI: -0.088, -0.046]), but not 13–15 months, in the main analysis. Results were broadly consistent across developmental domains.</p>
</sec>
<sec>
<title>Interpretation</title>
<p>COVID-19 PHSM were associated with increased developmental concerns among young children in Scotland. While leveraging interrupted time-series analysis yields findings consistent with a causal impact of PHSM, the influence of potential time-varying confounders cannot be ruled out.</p>
</sec>
</abstract>
</article-meta>
</front>
</article>